Corporate Profile
iRhythm is a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining our wearable biosensing technology with cloud-based data analytics and machine- learning capabilities. Our goal is to be the leading provider of first-line ambulatory electrocardiogram, or ECG, monitoring for patients at risk for arrhythmias.

We have created a unique platform, ZIO by iRhythm, which we believe allows physicians to diagnose many arrhythmias more quickly and efficiently than traditional technologies, avoiding multiple indeterminate tests, allowing for appropriate medical intervention and potentially avoiding more serious downstream medical events, including stroke.
IRTC (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) Stock is Up 3.45 (3.76%)
Data as of 09/25/18 4:00 p.m. ET
Refresh quote
Data provided by Nasdaq. Minimum 15 minutes delayed.
Stock chart for: IRTC.O.  Currently trading at $95.25 with a 52 week high of $98.37 and a 52 week low of $46.95.
Recent News
08/30/18iRhythm Technologies to Present at the Morgan Stanley 16th Annual Global Healthcare ConferencePrinter Friendly Version
08/01/18iRhythm Technologies Announces Second Quarter Financial ResultsPrinter Friendly Version
07/26/18iRhythm Technologies to Present at the Canaccord Genuity 38th Annual Growth ConferencePrinter Friendly Version
Upcoming Events
10/31/18 4:30 p.m. ET
Q3 2018 iRhythm Technologies Inc Earnings Conference Call